Ethyl Acetate

Ethyl Acetate

SCHEMBL70679

CCCCC.CCOC(C)=O

nearest known ligand 0.78

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.78
LMNA P02545 1/20 0.78
HSD17B10 Q99714 1/20 0.78
TSHR P16473 3/20 0.48
FAAH O00519 1/20 0.45
ALOX15 P16050 1/20 0.43
MGAM O43451 1/20 0.43
GAA P10253 1/20 0.43
SI P14410 1/20 0.43
MGAM2 Q2M2H8 1/20 0.43
SOAT1 P35610 1/20 0.43
ATM Q13315 2/20 0.41
MEN1 O00255 1/20 0.41
MAPT P10636 1/20 0.41
KMT2A Q03164 1/20 0.41
L3MBTL1 Q9Y468 1/20 0.41
CES1 P23141 2/20 0.40
TRPA1 O75762 1/20 0.40
NAAA Q02083 1/20 0.39
DGKA P23743 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Ethyl Acetate SCHEMBL16341512 1.00 ALDH1A1 (0.78) ALDH1A1LMNAHSD17B10TSHRFAAH
Ethyl Acetate SCHEMBL7649560 1.00 ALDH1A1 (0.78) ALDH1A1LMNAHSD17B10TSHRFAAH
Ethyl Acetate SCHEMBL5778793 1.00 ALDH1A1 (0.78) ALDH1A1LMNAHSD17B10TSHRFAAH
Ethyl Acetate SCHEMBL9730557 1.00 ALDH1A1 (0.78) ALDH1A1LMNAHSD17B10TSHRFAAH
Ethyl Acetate SCHEMBL18094221 1.00 ALDH1A1 (0.78) ALDH1A1LMNAHSD17B10TSHRFAAH
Ethyl Acetate SCHEMBL3445033 1.00 ALDH1A1 (0.78) ALDH1A1LMNAHSD17B10TSHRFAAH
Ethyl Acetate SCHEMBL5369947 1.00 ALDH1A1 (0.78) ALDH1A1LMNAHSD17B10TSHRFAAH
Ethyl Acetate SCHEMBL3445508 1.00 ALDH1A1 (0.78) ALDH1A1LMNAHSD17B10TSHRFAAH
Ethyl Acetate SCHEMBL1312859 1.00 ALDH1A1 (0.78) ALDH1A1LMNAHSD17B10TSHRFAAH
Ethyl Acetate SCHEMBL6887264 1.00 ALDH1A1 (0.78) ALDH1A1LMNAHSD17B10TSHRFAAH

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1513 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-110105300-B Method for synthesizing 2-trifluoroethyl substituted benzoxazole compound 福州大学 2023-04-14 CN claimed
CN-111939871-B Method for removing organic phosphide in pesticide residue cleaning of traditional Chinese medicinal materials 安徽冯了性中药材饮片有限公司 2023-02-17 CN claimed
CN-110105300-A A method of synthesis 2- trifluoroethyl replaces benzo oxazoline compound 福州大学 2019-08-09 CN claimed
CN-110078667-A A method of extracting huperzine 云南汉德生物技术有限公司 2019-08-02 CN claimed
CN-109111406-A The synthetic method of perfluoroalkyl or difluoromethyl -1,2,4- triazineon compounds 福州大学 2019-01-01 CN claimed
CN-107778270-A A kind of synthetic method of docetaxel 天津中新药业研究中心 2018-03-09 CN claimed
CN-106890104-A Foam hair colorant composition 宝洁公司 2017-06-27 CN claimed
US-4668839-A CHROMATOGRAPHY HER MAJESTY THE QUEEN IN RIGHT OF CANADA, AS REPRESENTED BY THE MINISTER OF ENERGY, MINES AND RESOURCES CANADA (CA) 1987-05-26 US claimed
WO-2025262156-A1 HYDROPHOBIC PHASE COMPOSITION COMPRISING DEHYDRATED LIPOSOMES WITH NUTRITIONAL SUPPLEMENT MIDRA B.V. (NL) 2025-12-26 WO disclosed
CN-118176199-A Tricyclic boric acid derivative and preparation method and application thereof 上海济煜医药科技有限公司 2024-06-11 CN disclosed
US-20240174626-A1 MONOMERS CONTAINING A 4-THIAZOLIDINONE UNIT AND THEIR POLYAMIDE, POLYESTER AND POLYURETHANE POLYCONDENSATES COMPAGNIE GENERALE DES ETABLISSEMENTS MICHELIN (FR) 2024-05-30 US disclosed
WO-2024074703-A1 BASE-MEDIATED DECONSTRUCTION OF EPOXY RESINS AARHUS UNIVERSITET (DK) 2024-04-11 WO disclosed
US-20240100199-A1 COMPOSITIONS, METHODS, AND SYSTEMS FOR THE SYNTHESIS AND USE OF IMAGING AGENTS LANTHEUS MEDICAL IMAGING, INC. (US) 2024-03-28 US disclosed
CN-113423711-B Thieno [3,2-B ] pyridine derivatives as UDP glycosyltransferase inhibitors and methods of use thereof 建新公司 2024-03-15 CN disclosed
US-4035415-A GASTROINTESTINAL DISORDERS CARLO ERBA, S.P.A. (IT) 1977-07-12 US disclosed
US-4034002-A Prostaglandin derivatives AMERICAN HOME PRODUCTS CORPORATION (US) 1977-07-05 US disclosed
US-4018758-A ANALGESICS PFIZER INC. (US) 1977-04-19 US disclosed
US-3978064-A ANALGESIC PFIZER INC. (US) 1976-08-31 US disclosed
US-3950329-A FLUORINATED CEPHALOSPORINS E. I. DU PONT DE NEMOURS AND COMPANY (US) 1976-04-13 US disclosed
US-3935259-A 2-HYDROXY-3-(UREIDOPHENOXY)PROPYL, CARDIAC BETA RECEPTOR INHIBITORS CIBA-GEIGY CORPORATION (US) 1976-01-27 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240100199-A1 COMPOSITIONS, METHODS, AND SYSTEMS FOR THE SYNTHESIS AND USE OF IMAGING AGENTS FABP3, TNNI3, TNNT2 ALDH1A1 3040/4885LMNA 1449/4885HSD17B10 4385/4885
US-20240174626-A1 MONOMERS CONTAINING A 4-THIAZOLIDINONE UNIT AND THEIR POLYAMIDE, POLYESTER AND POLYURETHANE POLYCONDENSATES TST, UROD, MPST ALDH1A1 106/4885LMNA 2281/4885HSD17B10 518/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.